Miral, Rosita O.

HRN: 24-11-86  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/27/2023
12/04/2023
IV
1.5
Q8
Cellulitis
Checking Final Appropriateness 
11/27/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/27/2023
12/04/2023
IV
600
Q8
Cellulitis
Checking Final Appropriateness 
11/29/2023
MUPIROCIN 2%, 15G (TUBE)
11/29/2023
12/05/2023
TOPICAL
Apply Thinly
Q12
Infected Wound, Left Leg
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: